Search results for " infarct"

showing 10 items of 1146 documents

Silent and symptomatic atrial fibrillation,during the acute phase of myocardial infarction : determinants and role of arginine methylated and oxidati…

2015

Atrial fibrillation (AF) is a frequent complication of acute myocardial infarction (AMI) with a poorer prognosis. Silent atrial fibrillation has been suggested to be frequent after AMI. However, most part of the studies has targeted only paroxysmal or persistent AF. Thus, Reduced Nitric Oxide availability and endothelial dysfunction has been recently recognized as a possible contributor to altered prognosis in AF. Asymmetric dimethylarginine (ADMA) can inhibit nitric oxide synthase and leads to endothelial dysfunction, inflammation and oxidative stress in multiple cardiovascular diseases. However, any study has addressed the relationship between ADMA levels and the occurrence of AF in AMI.W…

Fibrillation atriale silencieuse[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyAsymmetric diméthylarginine[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyAsymétrique diméthylarginineSilent Atrial fibrillationPronosticInfarctus du myocarde en phase aiguëAcute myocardial infarctionMonitoring ECG en continuPrognosisContinuous ECG monitoring[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

2019

Objective: Growth differentiation factor-8 (GDF8), also known as myostatin, is a member of the transforming growth factor-β superfamily that inhibits skeletal muscle growth. We aimed to investigate the association between GDF8 and peak troponin I levels after acute myocardial infarction (AMI). Methods: All consecutive patients admitted from June 2016 to February 2018 for type 1 AMI in the Coronary Care Unit of University Hospital of Dijon Bourgogne (France) were included in our prospective study. Blood samples were harvested on admission, and serum levels of GDF8 were measured using a commercially available enzyme-linked immunosorbent assay kit. Results: Among the 296 patients with type 1 A…

Fibrillation0303 health sciencesmedicine.medical_specialtybiologybusiness.industryGeneral Medicine030204 cardiovascular system & hematologymedicine.diseaseVentricular tachycardiaTroponin3. Good health03 medical and health sciences0302 clinical medicineDiabetes mellitusInternal medicineTroponin Ibiology.proteinCardiologyCoronary care unitMedicineMyocardial infarctionmedicine.symptombusinessProspective cohort study030304 developmental biologyJournal of Clinical Medicine
researchProduct

Fibrinogen as predictor of mortality in a 42-months follow-up after acute myocardial infarction

2002

Fibrinogen mortality acute myocardial infarction
researchProduct

Atherogenic Ratios in Patients with Recurrent Acute Coronary Syndrome and Receiving Statin Therapy: Clinical Usefullness as Cardiovascular Predictors

2015

Patients who have already suffered a vascular event require more and better control of cardiovascular risk factors. Different atherogenic indexes such as TC/HDLc, LDLc/HDLc, apoB/apoA-I, LDLc/apoB and non-HDLc/HDLc have been used to follow-up the patients because of their predictive capacity of the lipid profile. The aim of this study was to evaluate atherogenic ratios as a marker of the lipid residual risk in high-risk patients receiving statin therapy and to know the changes produced by previous lipid-lowering drugs treatment for a previous coronary event. The study including patients admitted to coronary care units of six Spanish tertiary hospitals for Acute Coronary Syndrome (ACS). A to…

First episodemedicine.medical_specialtyAcute coronary syndromeStatinApolipoprotein Bbiologymedicine.diagnostic_testmedicine.drug_classbusiness.industrymedicine.diseaseSurgeryCor MalaltiesResidual riskAnginaInternal medicinebiology.proteinmedicineCardiologylipids (amino acids peptides and proteins)Myocardial infarctionCardiology and Cardiovascular MedicineLipid profilebusiness
researchProduct

Circulating miRNA Fingerprint and Endothelial Function in Myocardial Infarction: Comparison at Acute Event and One-Year Follow-Up.

2022

MicroRNAs (miRNA) are major regulators of intercellular communication and key players in the pathophysiology of cardiovascular disease. This study aimed to determine the miRNA fingerprint in a cohort of 53 patients with acute myocardial infarction (AMI) with non-ST-segment elevation (NSTEMI) relative to miRNA expression in healthy controls (n = 51). miRNA expression was initially profiled by miRNA array in the serum of patients undergoing cardiac catheterization during NSTEMI (n = 8) and 1 year past the event (follow-up, n = 8) and validated in the entire cohort. In total, 58 miRNAs were differentially expressed during AMI (p < 0.05), while 36 were modified at follow-up (Fisher’s exact t…

Fisiologia cel·lularMicroRNAsMyocardial InfarctionmicroRNA profile; serum biomarker; myocardial infarction; endothelial cell; let-7e; angiogenesisCytokinesEndothelial CellsHumansGeneral MedicineCirculating MicroRNAMalalties coronàriesNon-ST Elevated Myocardial InfarctionFollow-Up StudiesCells
researchProduct

“Accent issue”: foreign accent syndrome following ischemic stroke

2019

Background: Foreign accent syndrome (FAS) is arare syndrome associated with altered speech rhythm and prosody, which listeners perceive as foreign; cerebrovascular accidents, tumors and multiple sclerosis are reported as possible causes of FAS. The pathophysiology of FAS is not yet understood. Case presentation: A 68-year-old Italian man was admitted to the EmergencyDepartment for non-fluent aphasia and dysarthria. Computed tomography (CT) scan did not show abnormalities; the patient was treated with systemic thrombolysis. A repeated brain CT and magnetic resonance imaging (MRI) confirmed an infarct in the left primary motor cortex and mild extension to cortico-subcortical frontal regions. …

Foreign accent syndromeMalemedicine.medical_specialtyNeurologyDermatologyProsodyAudiology03 medical and health sciencesDysarthria0302 clinical medicineAphasiaStress (linguistics)Motor speech disordersmedicineAphasiaHumans030212 general & internal medicineStrokeNeuroradiologyAgedSpeech disordersbusiness.industryMotor CortexGeneral MedicineCerebral Infarctionmedicine.diseaseForeign accent syndromeStrokePsychiatry and Mental healthSettore MED/26 - NeurologiaNeurology (clinical)medicine.symptombusiness030217 neurology & neurosurgery
researchProduct

Contractile Reserve and Extent of Transmural Necrosis in the Setting of Myocardial Stunning: Comparison at Cardiac MR Imaging

2010

To perform a comparison of cardiac magnetic resonance (MR) imaging-derived ejection fraction (EF) during low-dose dobutamine infusion (EF(D)) with the extent of segments with transmural necrosis in more than 50% of their wall thickness (ETN) for the prediction of major adverse cardiac events (MACEs) and late systolic recovery soon after a first ST-segment elevation myocardial infarction (STEMI).Institutional ethics committee approval and written informed consent were obtained. One hundred nineteen consecutive patients with a first STEMI, a depressed left ventricular EF, and an open infarct-related artery underwent MR imaging at 1 week after infarction. EF(D) and ETN (by using a 17-segment m…

Gadolinium DTPAMaleCardiac Catheterizationmedicine.medical_specialtyCardiotonic AgentsNecrosismedicine.medical_treatmentMyocardial InfarctionContrast MediaMagnetic Resonance Imaging CineNecrosisDobutamineInternal medicineAngioplastymedicineHumansRadiology Nuclear Medicine and imagingProspective StudiesMyocardial infarctionCardiac catheterizationMyocardial StunningMyocardial stunningChi-Square DistributionEjection fractionmedicine.diagnostic_testbusiness.industryAngioplastyMagnetic resonance imagingMiddle Agedmedicine.diseaseMyocardial ContractionArea Under CurveRetreatmentcardiovascular systemCardiologyRegression AnalysisFemaleStentsDobutaminemedicine.symptombusinessmedicine.drugRadiology
researchProduct

[Role of visual analysis of first-pass contrast-enhanced MRI in reperfused myocardial infarction].

2006

The aim of this work is to evaluate the relationship between improvement of regional myocardial function and visual analysis of contrast-enhanced (CE) MRI in patients after acute myocardial infarction. MRI was performed on 19 patients 1 and 11 weeks after a reperfused acute myocardial infarction. Perfusion data (first-pass images [FPI] and delayed CE images) were acquired after an intravenous bolus of gadolinium-DTPA and visually analyzed using a 17 segment model. Each segment was then classified in 3 groups, according to the presence or absence of FPI and CE patterns at baseline study: group 0: normal-appearing segments; group 1: segments with delayed hyper-enhancement but no early hypo-en…

Gadolinium DTPAMaleMyocardiumMyocardial InfarctionContrast MediaMyocardial Reperfusion[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicineRecovery of FunctionMiddle AgedImage EnhancementMagnetic Resonance Imaging[SDV.IB.MN] Life Sciences [q-bio]/Bioengineering/Nuclear medicine[ SDV.IB.MN ] Life Sciences [q-bio]/Bioengineering/Nuclear medicineEvaluation Studies as TopicHumansFemaleComputingMilieux_MISCELLANEOUSAngioplasty BalloonAgedRetrospective StudiesArchives des maladies du coeur et des vaisseaux
researchProduct

Influence of contrast agent dose and image acquisition timing on the quantitative determination of nonviable myocardial tissue using delayed contrast…

2004

BACKGROUND: Delayed contrast-enhanced magnetic resonance imaging (ceMRI) has been shown to identify areas of irreversible myocardial injury due to infarction (MI) with high spatial resolution, allowing precise quantification of nonviable (hyperenhanced) myocardium. The aim of our study was to investigate the size of nonviable myocardium quantitatively as a function of time post-contrast when inversion time is held constant in patients post-myocardial infarction using two contrast agent (CA) doses. METHODS: Nine patients with chronic MI underwent two MR scans on a 1.5 Tesla system. Contrast-enhanced MRI data in two short-axis (SA) slices were continuously acquired until 40 minutes after CA i…

Gadolinium DTPAMaleTime FactorsHeart VentriclesGadoliniummedia_common.quotation_subjectMyocardial InfarctionContrast Mediachemistry.chemical_elementInfarctionReference ValuesmedicineHumansContrast (vision)Image acquisitionRadiology Nuclear Medicine and imagingMyocardial infarctionContrast-enhanced Magnetic Resonance Imagingmedia_commonDose-Response Relationship DrugRadiological and Ultrasound Technologymedicine.diagnostic_testbusiness.industryMyocardiumMagnetic resonance imagingMiddle AgedImage Enhancementmedicine.diseaseMagnetic Resonance ImagingQuantitative determinationchemistryCardiology and Cardiovascular MedicineNuclear medicinebusiness
researchProduct

Area at Risk and Viability after Myocardial Ischemia and Reperfusion Can Be Determined by Contrast-Enhanced Cardiac Magnetic Resonance Imaging

2008

<i>Background/Aims:</i> Clinical differentiation between infarcted and viable myocardium in the ischemic area at risk is controversial. We investigated the potential of contrast-enhanced cardiac magnetic resonance imaging (ceCMRI) in determining the area at risk 24 h after ischemia. <i>Methods:</i> Myocardial ischemia was induced by percutaneous coronary intervention of the left anterior descending coronary artery in pigs. Coronary occlusion time was 30 min in group A, which caused little myocardial infarction and 45 min in group B, which led to irreversible damage. 24 h after reperfusion ceCMRI was performed at 2 and 15 min after administration of gadolinium-diethyl…

Gadolinium DTPAMalemedicine.medical_specialtyCell SurvivalSwinemedia_common.quotation_subjectMyocardial Reperfusion InjuryCoronary AngiographyMicrocirculationArea at riskNecrosisText miningCardiac magnetic resonance imagingInternal medicinemedicineAnimalsContrast (vision)cardiovascular diseasesMyocardial infarctionmedia_commonTissue Survivalmedicine.diagnostic_testbusiness.industryMyocardiumMagnetic resonance imagingmedicine.diseaseMagnetic Resonance Imagingcardiovascular systemCardiologyFemaleSurgeryRadiologybusinessReperfusion injuryEuropean Surgical Research
researchProduct